The Incidence and Survival Rate of Population-Based Pancreatic Cancer Patients: Shanghai Cancer Registry 2004-2009

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Luo, Jianfeng ^a   Xiao, Linhai ^a   Wu, Chunxiao ^b   Zheng, Ying ^b   Zhao, Naiqing ^a  

^a FUDAN UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CHINA; DISTANT METASTASIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS RESECTION; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME;

AGED; CHINA; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SURVIVAL RATE;

EID: 84885134310     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076052     Document Type: Article

References (28)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Chen W, Zheng R, Zhang S, Zhao P, Li G, et al. (2013) The incidences and mortalities of major cancers in China, 2009. Chin J Cancer 32: 106-112.
3. Ferlay J, Parkin DM, Steliarova-Foucher E, (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46: 765-781.
4. Baxter NN, Whitson BA, Tuttle TM, (2007) Trends in the treatment and outcome of pancreatic cancer in the United States. Ann Surg Oncol 14: 1320-1326.
5. Zell JA, Rhee JM, Ziogas A, Lipkin SM, Anton-Culver H, (2007) Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev 16: 546-552.
6. Lau MK, Davila JA, Shaib YH, (2010) Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States. Pancreas 39: 458-462.
7. Eloubeidi MA, Desmond RA, Wilcox CM, Wilson RJ, Manchikalapati P, et al. (2006) Prognostic factors for survival in pancreatic cancer: a population-based study. Am J Surg 192: 322-329.
8. Sener SF, Fremgen A, Menck HR, Winchester DP, (1999) Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 189: 1-7.
9. Zhang QH, Ni QX, (2004) [Clinical analysis of 2340 cases of pancreatic cancer]. Zhonghua Yi Xue Za Zhi 84: 214-218.
10. Shen CM, Niu GC, Cui W, Li Q, (2012) Improvement of surgical and survival outcomes of patients with pancreatic cancer who underwent pancreaticoduodenectomy: a Chinese experience. Pancreatology 12: 206-210.
11. Ouyang H, Wang P, Meng Z, Chen Z, Yu E, et al. (2011) Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine. Pancreas 40: 120-125.
12. Ben Q, Wang K, Yuan Y, Li Z, (2011) Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study. Int J Cancer 128: 1179-1186.
13. Dong M, Nio Y, Guo KJ, Tamura K, Tian YL, et al. (1998) Epidermal growth factor and its receptor as prognostic indicators in Chinese patients with pancreatic cancer. Anticancer Res 18: 4613-4619.
14. (2008) Cancer incidence in five continents. Volume IX. IARC Sci Publ: 1-837.
15. Doll R, Cook P, (1967) Summarizing indices for comparison of cancer incidence data. Int J Cancer 2: 269-279.
16. Chen WQ, Zeng HM, Zheng RS, Zhang SW, He J, (2012) Cancer incidence and mortality in china, 2007. Chin J Cancer Res 24: 1-8.
17. Shaib YH, Davila JA, El-Serag HB, (2006) The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther 24: 87-94.
18. Zheng S, Li Q, Huang D, (2003) Surgical treatment of pancreatic cancer: a follow-up study in 216 cases. Chinese Journal of Hepatobiliary Surgery 9: 134-136.
19. Meyer W, Jurowich C, Reichel M, Steinhauser B, Wunsch PH, et al. (2000) Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas. Surg Today 30: 582-587.
20. Distler M, Ruckert F, Hunger M, Kersting S, Pilarsky C, et al. (2013) Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma. BMC Surg 13: 12.
21. Kuhlmann KF, de Castro SM, Wesseling JG, ten Kate FJ, Offerhaus GJ, et al. (2004) Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer 40: 549-558.
22. Garcea G, Dennison AR, Pattenden CJ, Neal CP, Sutton CD, et al. (2008) Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP 9: 99-132.
23. Takai S, Satoi S, Toyokawa H, Yanagimoto H, Sugimoto N, et al. (2003) Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas 26: 243-249.
24. Ni QX, Zhang QH, Fu DL, Cao GH, Yao QY, et al. (2002) Curative resection of pancreatic head carcinoma in recent 30 years: report of 377 cases. Hepatobiliary Pancreat Dis Int 1: 126-128.
25. Lim JE, Chien MW, Earle CC, (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237: 74-85.
26. Gudjonsson B, (2002) Survival statistics gone awry: pancreatic cancer, a case in point. J Clin Gastroenterol 35: 180-184.
27. Shaib Y, Davila J, Naumann C, El-Serag H, (2007) The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study. Am J Gastroenterol 102: 1377-1382.
28. Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, et al. (2008) Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 247: 456-462.